SENSEX
NIFTY
GOLD
USD/INR

Weather

image 32    C

Economy News

The Economic Times

Economy / The Economic Times

details

Eli Lillys obesity drug shows up to 30% weight loss in trial

Eli Lilly's new obesity drug retatrutide shows remarkable results. In a major trial, patients lost up to 30% of their body weight. This once-weekly injection targets multiple hormone receptors. The drug also improved heart health markers. Experts believe retatrutide could be a game-changer for treating obesity and improving patient health.

21 May 2026 10:28 pm